Cabinet Expert Scientifique et Réglementaire
Cabinet Expert Scientifique et Réglementaire
This prospective randomized placebo-controlled clinical trial was conducted to evaluate the neuroprotective role of phosphoserine in primary open-angle glaucoma (POAG) patients. To do so, 51 POAG patients were randomized to receive either 60 mg/100 mL of phosphoserine or placebo for …
This placebo-controlled, double-blind, matched-paired study assessed the impact of Eurycoma longifolia on the hypothalamic-pituitary-gonadal and hypothalamic-pituitary-adrenal axes in healthy young males (n=32) who received 600 mg/day of Eurycoma longifolia or placebo for 2 weeks. Blood analysis showed significant interaction and …
This single arm, pilot study, has examined the effects of a Bifidobacterium animalis subsp. lactis BB-12 supplementation in young divers (9.10 ± 1.80 years) under stress conditions. They received 109 CFU/100 g daily for 8 weeks. Results showed an improvement …
This randomized, double-blind and placebo-controlled pilot clinical trial was conducted on 95 asymptomatic patients with COVID-19 infection receiving either 1 g of Giloy Ghanvati (Tinospora cordifolia) and 2 g of Swasari Ras (traditional herbo-mineral formulation) and 0.5 g each of …
EFSA has launched a consultation on its draft opinion on alpha-lipoic acid (ALA). Following a request from the European Commission, this document discusses data on the relationship between intake of alpha-lipoic acid (or thioctic acid) and the risk of insulin …
A case report in a 44-year-old male physician who was confirmed COVID-19 positive has been recently published. He was sent for home isolation with no treatment given. The patient received a home-made TaibUVID nutritional supplement (Nigella sativa, chamomile and natural …
This phase II prospective, randomized double-blinded, placebo-controlled study was conducted to determine the efficacy and safety of a novel whole tomato-based food supplement (WTFS) on lower urinary tract symptoms (LUTS) of patients diagnosed with benign prostatic hyperplasia (BPH). To do …
COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which binds to angiotensin-converting enzyme 2 (ACE2) on the cell surface and downregulates ACE2, likely elevating the ratio of angiotensin-converting enzyme (ACE) to ACE2. The overreaction of the immune …
Curcumin is proposed as a potential treatment option for coronavirus disease-19 (COVID-19). An open-label non-randomized clinical trial evaluated the efficacy of nano-curcumin oral formulation in 41 hospitalized patients with mild-moderate COVID-19. Subjects were allocated to nano-curcumin (n = 21; Sinacurcumin …